400
Participants
Start Date
June 29, 2020
Primary Completion Date
June 15, 2021
Study Completion Date
June 15, 2021
011516X (New Artificial Tear Formulation)
Topical eye drops
Systane Ultra Multidose
Topical eye drops
REFRESH PLUS®
Topical eye drops
Rochester Ophthalmological Group, PC, Rochester
Wake Forest Health Network Ophthalmology - Oak Hollow, High Point
Clayton Eye Clinical Research, LLC, Morrow
Georgia Eye Partners, Atlanta
Bowden Eye & Associates, Jacksonville
Clinical Research Center of Florida, Pompano Beach
South Florida Research Center, Inc., Miami
Vista Health Research, LLC, Miami
Nature Coast Clinical Research, Crystal River
Advancing Vision Research, Nashville
Total Eye Care, PA, Memphis
Senior Health Services, Louisville
Eye Care Associates of Greater Cincinnati, Inc. dba Apex Eye, Cincinnati
Ophthalmology Associates, Saint Charles
Moyes Eye Center, Kansas City
Kannarr Eye Care, LLC, Pittsburg
Alliance for Multispecialty Research, LLC, Newton
DCT-Shah Research, LLC dba Discovery Clinical Trials, Mission
Eye Care Associates of Nevada, Sparks
Wolstan & Goldberg Eye Associates, Torrance
Global Research Management, Glendale
Milton M. Hom, OD, FAAO, Azusa
North Bay Eye Associates, Inc., Petaluma
Eric M. White OD Inc, San Diego
Eye Research Foundation, Newport Beach
West Bay Eye Associates, Warwick
Lead Sponsor
Allergan
INDUSTRY